Skip to main content
OpenTrials

Clinical trial condition

Stage IV Cutaneous Melanoma AJCC v6 and v7

Explore clinical trials studying Stage IV Cutaneous Melanoma AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

31 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Cutaneous Melanoma AJCC v6 and v7 trial results

Completed

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

NCT02304458

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 25 locations
View Trial Details
Completed

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

NCT02129075

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

NCT02158520

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +19 more
Locations
  • Saint Mary's Medical Center San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Illinois Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 13 locations
View Trial Details
Completed

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01258855

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Completed

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery

NCT00861913

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

NCT01727076

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

NCT01274338

Conditions
Melanoma, Melanoma of Unknown Primary, Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 938 locations
View Trial Details
Active, Not Recruiting

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

NCT02339571

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • John L McClellan Memorial Veterans Hospital Little Rock, Arkansas, United States
View all 764 locations
View Trial Details

Related conditions